Phase 1 study of the antibody-drug conjugate (ADC) SGN-LIV1A in patients with heavily pretreated metastatic breast cancer Meeting Abstract


Authors: Forero-Torres, A.; Modi, S.; Specht, J.; Miller, K.; Weise, A.; Burris, H.; Liu, M.; Krop, I.; Pusztai, L.; Kostic, A.; Li, M.; Mita, M.
Abstract Title: Phase 1 study of the antibody-drug conjugate (ADC) SGN-LIV1A in patients with heavily pretreated metastatic breast cancer
Meeting Title: 2016 San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 77
Issue: 4 Suppl.
Meeting Dates: 2016 Dec 6-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2017-02-01
Language: English
ACCESSION: WOS:000397999002317
DOI: 10.1158/1538-7445.sabcs16-p6-12-04
PROVIDER: wos
Notes: Meeting Abstract: P6-12-04 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Shanu Modi
    265 Modi
  2. Ming Li
    110 Li
  3. Ming Liu
    15 Liu